Here is a current table of stocks from the healthcare sector with a positive dividend yield as well as an earnings per share growth for the next five years of at least 15 percent yearly. Twelve stocks fulfilled these criteria of which three are yielding above three percent.
Here are the three top dividend stocks by market capitalization:
Shire Plc (SHPGY, Financial) hasa market capitalization of $18.82 billion. The company employs 4,183 people, generates revenues of $3,471.10 million and has a net income of $586.60 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $1,043.40 million. Because of these figures, the EBITDA margin is 30.06 percent (operating margin 22.73 percent and the net profit margin finally 16.90 percent).
The total debt representing 20.56 percent of the company’s assets and the total debt in relation to the equity amounts to 45.19 percent. Due to the financial situation, the return on equity amounts to 26.95 percent. Finally, earnings per share amounts to $4.07 of which $0.39 were paid in form of dividends to shareholders last fiscal.
Here are the price ratios of the company: The P/E ratio is 24.64, Price/Sales 5.14 and Price/Book ratio 7.37. Dividend Yield: 0.48 percent. The beta ratio is 0.80.
Dr. Reddy's Laboratorires (RDY, Financial) hasa market capitalization of $5.07 billion. The company employs 14,923 people, generates revenues of $1,439.17 million and has a net income of $212.72 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $323.26 million. Because of these figures, the EBITDA margin is 22.46 percent (operating margin 16.91 percent and the net profit margin finally 14.78 percent).
The total debt representing 24.81 percent of the company’s assets and the total debt in relation to the equity amounts to 51.25 percent. Due to the financial situation, the return on equity amounts to 24.84 percent. Finally, earnings per share amounts to $1.33 of which $0.22 were paid in form of dividends to shareholders last fiscal.
Here are the price ratios of the company: The P/E ratio is 22.53, Price/Sales 3.62 and Price/Book ratio 5.79. Dividend Yield: 0.84 percent. The beta ratio is 1.08.
Pharmaceutical Products (PPDI, Financial) hasa market capitalization of $3.78 billion. The company employs 11,000 people, generates revenues of $1,470.57 million and has a net income of $127.33 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $247.55 million. Because of these figures, the EBITDA margin is 16.83 percent (operating margin 12.41 percent and the net profit margin finally 8.66 percent).
The total debt representing 0.00 percent of the company’s assets and the total debt in relation to the equity amounts to 0.00 percent. Due to the financial situation, the return on equity amounts to 9.72 percent. Finally, earnings per share amounts to $1.43 of which $0.60 were paid in form of dividends to shareholders last fiscal.
Here are the price ratios of the company: The P/E ratio is 23.23, Price/Sales 2.57 and Price/Book ratio 3.09. Dividend Yield: 1.81 percent. The beta ratio is 0.71.
Take a closer look at the full table of healthcare stocks with fast EPS growth. The average price to earnings ratio (P/E ratio) amounts to 20.57 while the forward price to earnings ratio is 15.38. The dividend yield has a value of 1.80 percent. Price to book ratio is 3.12 and price to sales ratio 2.21. The operating margin amounts to 13.74 percent. Earnings per share are expected to grow by 17.73 yearly for the next five years.
Related stock ticker symbols:
VIVO, LNCR, MSA, WST, PPDI, USPH, LMAT, RELV, MR, RDY, CMN, SHPGY
Selected Articles:
· 5 Cheap Healthcare Dividend Stocks By PEG Ratio
· 14 Healthcare Dividend Stocks With Biggest Institutional Buys
· 18 Low Beta Healthcare Stocks With Best Dividend Yields
· High Yields From Healthcare Sector
Here are the three top dividend stocks by market capitalization:
Shire Plc (SHPGY, Financial) hasa market capitalization of $18.82 billion. The company employs 4,183 people, generates revenues of $3,471.10 million and has a net income of $586.60 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $1,043.40 million. Because of these figures, the EBITDA margin is 30.06 percent (operating margin 22.73 percent and the net profit margin finally 16.90 percent).
The total debt representing 20.56 percent of the company’s assets and the total debt in relation to the equity amounts to 45.19 percent. Due to the financial situation, the return on equity amounts to 26.95 percent. Finally, earnings per share amounts to $4.07 of which $0.39 were paid in form of dividends to shareholders last fiscal.
Here are the price ratios of the company: The P/E ratio is 24.64, Price/Sales 5.14 and Price/Book ratio 7.37. Dividend Yield: 0.48 percent. The beta ratio is 0.80.
Dr. Reddy's Laboratorires (RDY, Financial) hasa market capitalization of $5.07 billion. The company employs 14,923 people, generates revenues of $1,439.17 million and has a net income of $212.72 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $323.26 million. Because of these figures, the EBITDA margin is 22.46 percent (operating margin 16.91 percent and the net profit margin finally 14.78 percent).
The total debt representing 24.81 percent of the company’s assets and the total debt in relation to the equity amounts to 51.25 percent. Due to the financial situation, the return on equity amounts to 24.84 percent. Finally, earnings per share amounts to $1.33 of which $0.22 were paid in form of dividends to shareholders last fiscal.
Here are the price ratios of the company: The P/E ratio is 22.53, Price/Sales 3.62 and Price/Book ratio 5.79. Dividend Yield: 0.84 percent. The beta ratio is 1.08.
Pharmaceutical Products (PPDI, Financial) hasa market capitalization of $3.78 billion. The company employs 11,000 people, generates revenues of $1,470.57 million and has a net income of $127.33 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $247.55 million. Because of these figures, the EBITDA margin is 16.83 percent (operating margin 12.41 percent and the net profit margin finally 8.66 percent).
The total debt representing 0.00 percent of the company’s assets and the total debt in relation to the equity amounts to 0.00 percent. Due to the financial situation, the return on equity amounts to 9.72 percent. Finally, earnings per share amounts to $1.43 of which $0.60 were paid in form of dividends to shareholders last fiscal.
Here are the price ratios of the company: The P/E ratio is 23.23, Price/Sales 2.57 and Price/Book ratio 3.09. Dividend Yield: 1.81 percent. The beta ratio is 0.71.
Take a closer look at the full table of healthcare stocks with fast EPS growth. The average price to earnings ratio (P/E ratio) amounts to 20.57 while the forward price to earnings ratio is 15.38. The dividend yield has a value of 1.80 percent. Price to book ratio is 3.12 and price to sales ratio 2.21. The operating margin amounts to 13.74 percent. Earnings per share are expected to grow by 17.73 yearly for the next five years.
Related stock ticker symbols:
VIVO, LNCR, MSA, WST, PPDI, USPH, LMAT, RELV, MR, RDY, CMN, SHPGY
Selected Articles:
· 5 Cheap Healthcare Dividend Stocks By PEG Ratio
· 14 Healthcare Dividend Stocks With Biggest Institutional Buys
· 18 Low Beta Healthcare Stocks With Best Dividend Yields
· High Yields From Healthcare Sector
